Knowledge on the molecular mechanisms of colorectal carcinogenesis is major goal; many relevant studies have demonstrated association between CRC and different polymorphisms on KRAS gene, such as rs712 polymorphism that has been shown to alter the let-7 binding site and regulate KRAS activity affecting gene expression and promoting the cell proliferation in the intestinal mucosa (12, 16). This evidence concerns the gene KRAS and medical procedure.